Pura Vida Investments as of June 30, 2015
Portfolio Holdings for Pura Vida Investments
Pura Vida Investments holds 62 positions in its portfolio as reported in the June 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Teleflex Incorporated (TFX) | 6.8 | $13M | 99k | 134.00 | |
CIGNA Corporation | 4.8 | $9.4M | 65k | 144.06 | |
Universal Hlth Svcs CL B (UHS) | 4.5 | $8.7M | 60k | 145.23 | |
Alimera Sciences | 3.1 | $6.0M | 1.2M | 4.82 | |
Sientra | 2.9 | $5.6M | 241k | 23.25 | |
Spectranetics Corporation | 2.9 | $5.6M | 325k | 17.10 | |
NuVasive | 2.7 | $5.2M | 94k | 55.01 | |
NxStage Medical | 2.6 | $5.1M | 360k | 14.28 | |
Pfizer (PFE) | 2.6 | $5.1M | 143k | 36.06 | |
Stryker Corporation (SYK) | 2.6 | $5.1M | 50k | 102.28 | |
Thermo Fisher Scientific Call Call Option (TMO) | 2.5 | $4.9M | 38k | 129.76 | |
Cooper Cos Com New | 2.3 | $4.4M | 25k | 177.00 | |
Boston Scientific Corporation (BSX) | 2.1 | $4.1M | 235k | 17.34 | |
Abbvie (ABBV) | 2.1 | $4.0M | 57k | 70.01 | |
Smith & Nephew Spdn Adr New (SNN) | 2.0 | $3.9M | 105k | 37.01 | |
FEI Company | 2.0 | $3.9M | 45k | 86.00 | |
Agilent Technologies Call Call Option (A) | 2.0 | $3.9M | 100k | 38.58 | |
Edwards Lifesciences (EW) | 2.0 | $3.8M | 25k | 152.16 | |
Vanda Pharmaceuticals (VNDA) | 1.9 | $3.8M | 308k | 12.24 | |
Owens & Minor (OMI) | 1.9 | $3.7M | 105k | 35.16 | |
Cyberonics | 1.9 | $3.7M | 60k | 61.40 | |
Ptc Therapeutics Call Call Option (PTCT) | 1.9 | $3.6M | 75k | 48.13 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.8 | $3.5M | 18k | 192.22 | |
Insulet Corporation (PODD) | 1.7 | $3.4M | 100k | 33.89 | |
Cepheid | 1.7 | $3.3M | 60k | 55.58 | |
Bristol Myers Squibb (BMY) | 1.7 | $3.3M | 51k | 65.64 | |
Perrigo SHS (PRGO) | 1.7 | $3.3M | 17k | 192.18 | |
Affymetrix | 1.7 | $3.3M | 300k | 10.96 | |
Valeant Pharmaceuticals Int | 1.7 | $3.2M | 13k | 257.52 | |
Cynapsus Therapeutics Com Par No Par | 1.6 | $3.1M | 195k | 16.18 | |
Wright Medical | 1.6 | $3.1M | 120k | 25.84 | |
Biogen Idec (BIIB) | 1.5 | $2.9M | 9.3k | 318.81 | |
Qiagen Nv Reg Shs | 1.4 | $2.8M | 100k | 27.98 | |
Accuray Incorporated (ARAY) | 1.4 | $2.7M | 430k | 6.38 | |
Kite Pharma | 1.3 | $2.6M | 36k | 72.78 | |
Receptos | 1.3 | $2.5M | 11k | 227.82 | |
Transenterix Com New | 1.3 | $2.5M | 762k | 3.27 | |
Alexion Pharmaceuticals | 1.3 | $2.5M | 13k | 197.44 | |
Allergan | 1.2 | $2.3M | 7.0k | 331.14 | |
Synergy Pharmaceuticals Del Com New | 1.2 | $2.2M | 246k | 9.12 | |
Eli Lilly & Co. (LLY) | 1.1 | $2.2M | 27k | 84.53 | |
Thoratec Corp Put Put Option | 1.1 | $2.2M | 50k | 44.58 | |
Wright Medical Group Rights Right 03/01/2019 | 1.1 | $2.2M | 586k | 3.71 | |
Akorn | 1.1 | $2.2M | 47k | 46.10 | |
Esperion Therapeutics Inc Ne Put Put Option (ESPR) | 1.1 | $2.1M | 35k | 62.00 | |
Alliqua Biomedical Com New | 1.1 | $2.1M | 420k | 4.98 | |
Catalyst Pharmaceutical Partners (CPRX) | 1.0 | $2.0M | 395k | 4.94 | |
Sage Therapeutics (SAGE) | 1.0 | $1.9M | 28k | 68.36 | |
Tonix Pharmaceuticals Hldg C Com New | 0.7 | $1.3M | 158k | 8.43 | |
Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.5 | $1.0M | 100k | 10.45 | |
Impax Laboratories | 0.5 | $1.0M | 22k | 48.46 | |
Neuroderm Ord Shs | 0.5 | $1.0M | 53k | 18.98 | |
Zogenix | 0.5 | $978k | 51k | 19.32 | |
Cymabay Therapeutics | 0.3 | $602k | 200k | 3.01 | |
Dyax | 0.3 | $554k | 23k | 24.62 | |
Aldeyra Therapeutics (ALDX) | 0.3 | $511k | 58k | 8.89 | |
Ocera Therapeutics | 0.2 | $460k | 117k | 3.92 | |
Adamis Pharmaceuticals Corp Com New | 0.2 | $337k | 81k | 4.19 | |
Carbylan Therapeutics Inc Common Stock Usd 0.001 | 0.1 | $276k | 40k | 6.90 | |
Lombard Med (EVARF) | 0.1 | $216k | 53k | 4.09 | |
Sarepta Therapeutics Call Call Option (SRPT) | 0.1 | $164k | 5.4k | 30.37 | |
Staar Surgical Com Par $0.01 (STAA) | 0.1 | $151k | 17k | 8.78 |